TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.

Alongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar...

Full description

Bibliographic Details
Main Authors: Nancy Vargas, Silvia Álvarez-Cubela, Jaime A Giraldo, Margarita Nieto, Nicholas M Fort, Sirlene Cechin, Enrique García, Pedro Espino-Grosso, Christopher A Fraker, Camillo Ricordi, Luca Inverardi, Ricardo L Pastori, Juan Domínguez-Bendala
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3150355?pdf=render
_version_ 1819052229438472192
author Nancy Vargas
Silvia Álvarez-Cubela
Jaime A Giraldo
Margarita Nieto
Nicholas M Fort
Sirlene Cechin
Enrique García
Pedro Espino-Grosso
Christopher A Fraker
Camillo Ricordi
Luca Inverardi
Ricardo L Pastori
Juan Domínguez-Bendala
author_facet Nancy Vargas
Silvia Álvarez-Cubela
Jaime A Giraldo
Margarita Nieto
Nicholas M Fort
Sirlene Cechin
Enrique García
Pedro Espino-Grosso
Christopher A Fraker
Camillo Ricordi
Luca Inverardi
Ricardo L Pastori
Juan Domínguez-Bendala
author_sort Nancy Vargas
collection DOAJ
description Alongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar cells into insulin-producing beta cells. These experiments set the stage for the development of new strategies to address the impairment of glycemic control in diabetic patients. However, the clinical applicability of reprogramming in this context is deemed to be poor due to the need to use viral vehicles for the delivery of the above factors. Here we describe a recombinant transducible version of the MafA protein (TAT-MafA) that penetrates across cell membranes with an efficiency of 100% and binds to the insulin promoter in vitro. When injected in utero into living mouse embryos, TAT-MafA significantly up-regulates target genes and induces enhanced insulin production as well as cytoarchitectural changes consistent with faster islet maturation. As the latest addition to our armamentarium of transducible proteins (which already includes Pdx1 and Ngn3), the purification and characterization of a functional TAT-MafA protein opens the door to prospective therapeutic uses that circumvent the use of viral delivery. To our knowledge, this is also the first report on the use of protein transduction in utero.
first_indexed 2024-12-21T12:16:31Z
format Article
id doaj.art-c77a0084b2e34d4f9d9c6b647d41f407
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T12:16:31Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c77a0084b2e34d4f9d9c6b647d41f4072022-12-21T19:04:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2236410.1371/journal.pone.0022364TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.Nancy VargasSilvia Álvarez-CubelaJaime A GiraldoMargarita NietoNicholas M FortSirlene CechinEnrique GarcíaPedro Espino-GrossoChristopher A FrakerCamillo RicordiLuca InverardiRicardo L PastoriJuan Domínguez-BendalaAlongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar cells into insulin-producing beta cells. These experiments set the stage for the development of new strategies to address the impairment of glycemic control in diabetic patients. However, the clinical applicability of reprogramming in this context is deemed to be poor due to the need to use viral vehicles for the delivery of the above factors. Here we describe a recombinant transducible version of the MafA protein (TAT-MafA) that penetrates across cell membranes with an efficiency of 100% and binds to the insulin promoter in vitro. When injected in utero into living mouse embryos, TAT-MafA significantly up-regulates target genes and induces enhanced insulin production as well as cytoarchitectural changes consistent with faster islet maturation. As the latest addition to our armamentarium of transducible proteins (which already includes Pdx1 and Ngn3), the purification and characterization of a functional TAT-MafA protein opens the door to prospective therapeutic uses that circumvent the use of viral delivery. To our knowledge, this is also the first report on the use of protein transduction in utero.http://europepmc.org/articles/PMC3150355?pdf=render
spellingShingle Nancy Vargas
Silvia Álvarez-Cubela
Jaime A Giraldo
Margarita Nieto
Nicholas M Fort
Sirlene Cechin
Enrique García
Pedro Espino-Grosso
Christopher A Fraker
Camillo Ricordi
Luca Inverardi
Ricardo L Pastori
Juan Domínguez-Bendala
TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
PLoS ONE
title TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
title_full TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
title_fullStr TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
title_full_unstemmed TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
title_short TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.
title_sort tat mediated transduction of mafa protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology
url http://europepmc.org/articles/PMC3150355?pdf=render
work_keys_str_mv AT nancyvargas tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT silviaalvarezcubela tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT jaimeagiraldo tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT margaritanieto tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT nicholasmfort tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT sirlenecechin tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT enriquegarcia tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT pedroespinogrosso tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT christopherafraker tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT camilloricordi tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT lucainverardi tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT ricardolpastori tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology
AT juandominguezbendala tatmediatedtransductionofmafaproteininuteroresultsinenhancedpancreaticinsulinexpressionandchangesinisletmorphology